The Clinical outcomes, healthcare resource utilization, and related costs (COHERENT) model. Application in heart failure patients.

Héctor Bueno, José L Bernal,Víctor Jiménez-Jiménez, Francisco Javier Martín-Sánchez,Xavier Rossello, Guillermo Moreno, Clara Goñi,Víctor Gil, Pere Llorens,Nerea Naranjo, Javier Jacob,Pablo Herrero-Puente, Sergio Garrote,Juan Carlos Silla-Castro, Stuart J Pocock,Òscar Miró

Revista espanola de cardiologia (English ed.)(2021)

引用 4|浏览20
暂无评分
摘要
INTRODUCTION AND OBJECTIVES:Composite endpoints are widely used but have several limitations. The Clinical outcomes, healthcare resource utilization and related costs (COHERENT) model is a new approach for visually displaying and comparing composite endpoints including all their components (incidence, timing, duration) and related costs. We aimed to assess the validity of the COHERENT model in a patient cohort. METHODS:A color graphic system displaying the percentage of patients in each clinical situation (vital status and location: at home, emergency department [ED] or hospital) and related costs at each time point during follow-up was created based on a list of mutually exclusive clinical situations coded in a hierarchical fashion. The system was tested in a cohort of 1126 patients with acute heart failure from 25 hospitals. The system calculated and displayed the time spent in each clinical situation and health care resource utilization-related costs over 30 days. RESULTS:The model illustrated the times spent over 30 days (2.12% in ED, 23.6% in index hospitalization, 2.7% in readmissions, 65.5% alive at home, and 6.02% dead), showing significant differences between patient groups, hospitals, and health care systems. The tool calculated and displayed the daily and cumulative health care-related costs over time (total, €4 895 070; mean, €144.91 per patient/d). CONCLUSIONS:The COHERENT model is a new, easy-to-interpret, visual display of composite endpoints, enabling comparisons between patient groups and cohorts, including related costs. The model may constitute a useful new approach for clinical trials or observational studies, and a tool for benchmarking, and value-based health care implementation.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要